Drug Shortage Report for ARZERRA

Last updated on 2018-09-27 History
Report ID 4093
Drug Identification Number 02381567
Brand name ARZERRA
Common or Proper name Arzerra 1000MG VIALS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) Ofatumumab
Strength(s) 1000MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50ML X 1
ATC code L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-02-28
Estimated end date
Actual end date 2018-09-26
Shortage status Resolved
Updated date 2018-09-27
Company comments Product will be discontinued. Communication letter to follow.
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-09-27 English Compare
v4 2018-09-26 French Compare
v3 2018-09-26 English Compare
v2 2017-03-23 French Compare
v1 2017-03-23 English Compare